Mizobata Yasumitsu
Department of Traumatology and Critical Care Medicine, Graduate School of Medicine, Osaka City University, 1-4-3 Asahimachi, Abeno-ku, Osaka City, Osaka, 545-8585, Japan.
J Intensive Care. 2017 Jan 20;5(1):4. doi: 10.1186/s40560-016-0197-5.
Coagulopathy observed in trauma patients was thought to be a resuscitation-associated phenomenon. The replacement of lost and consumed coagulation factors was the mainstay in the resuscitation of hemorrhagic shock for many decades. Twenty years ago, damage control surgery (DCS) was implemented to challenge the coagulopathy of trauma. It consists of three steps: abbreviated surgery to control the hemorrhage and contamination, resuscitation in the intensive care unit (ICU), and planned re-operation with definitive surgery. The resuscitation strategy of DCS focused on the rapid reversal of acidosis and prevention of hypothermia through the first two steps. However, direct treatment of coagulopathy was not emphasized in DCS.Recently, better understanding of the pathophysiology of coagulopathy in trauma patients has led to the logical opinion that we should directly address this coagulopathy during major trauma resuscitation. Damage control resuscitation (DCR), the strategic approach to the trauma patient who presents in extremis, consists of balanced resuscitation, hemostatic resuscitation, and prevention of acidosis, hypothermia, and hypocalcemia. In balanced resuscitation, fluid administration is restricted and hypotension is allowed until definitive hemostatic measures begin. The administration of blood products consisting of fresh frozen plasma, packed red blood cells, and platelets, the ratio of which resembles whole blood, is recommended early in the resuscitation.DCR strategy is now the most beneficial measure available to address trauma-induced coagulopathy, and it can change the treatment strategy of trauma patients. DCS is now incorporated as a component of DCR. DCR as a structured intervention begins immediately after rapid initial assessment in the emergency room and progresses through the operating theater into the ICU in combination with DCS. By starting from ground zero with the performance of DCS, DCR allows the trauma surgeon to correct the coagulopathy of trauma. The effect of the reversal of coagulopathy in massively hemorrhagic patients may change the operative strategy with DCS.
创伤患者中观察到的凝血病被认为是一种与复苏相关的现象。几十年来,补充丢失和消耗的凝血因子一直是失血性休克复苏的主要手段。二十年前,损伤控制外科手术(DCS)被用于应对创伤性凝血病。它包括三个步骤:进行简短手术以控制出血和污染、在重症监护病房(ICU)进行复苏以及计划进行确定性手术的再次手术。DCS的复苏策略在前两个步骤中侧重于快速纠正酸中毒和预防体温过低。然而,DCS并未强调对凝血病的直接治疗。
最近,对创伤患者凝血病病理生理学的更好理解得出了一个合理的观点,即我们应该在重大创伤复苏期间直接处理这种凝血病。损伤控制复苏(DCR)是针对处于危急状态的创伤患者的战略方法,包括平衡复苏、止血复苏以及预防酸中毒、体温过低和低钙血症。在平衡复苏中,限制液体输注并允许出现低血压,直到开始采取确定性止血措施。建议在复苏早期给予由新鲜冰冻血浆、浓缩红细胞和血小板组成的血液制品,其比例类似于全血。
DCR策略是目前应对创伤性凝血病最有益的措施,它可以改变创伤患者的治疗策略。DCS现在已被纳入DCR的一个组成部分。DCR作为一种结构化干预措施,在急诊室进行快速初步评估后立即开始,并结合DCS从手术室推进到ICU。通过从DCS的实施开始从头做起,DCR使创伤外科医生能够纠正创伤性凝血病。在大量出血患者中逆转凝血病的效果可能会改变DCS的手术策略。